[HTML][HTML] Role of novel biomarkers in diabetic cardiomyopathy

M Kumric, TT Kurir, JA Borovac, J Bozic - World journal of diabetes, 2021 - ncbi.nlm.nih.gov
Diabetic cardiomyopathy (DCM) is commonly defined as cardiomyopathy in patients with
diabetes mellitus in the absence of coronary artery disease and hypertension. As DCM is …

Female heart health: is GPER the missing link?

L Groban, QK Tran, CM Ferrario, X Sun… - Frontiers in …, 2020 - frontiersin.org
The G Protein-Coupled Estrogen Receptor (GPER) is a novel membrane-bound receptor
that mediates non-genomic actions of the primary female sex hormone 17β-estradiol …

An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG …

Y Huang, K Zhang, M Liu, J Su, X Qin, X Wang… - Phytomedicine, 2021 - Elsevier
Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous
disease presenting a substantial challenge to clinicians. Currently, there is no safe and …

Mitochondrial Ca2+, redox environment and ROS emission in heart failure: two sides of the same coin?

S Cortassa, M Juhaszova, MA Aon, DB Zorov… - Journal of molecular and …, 2021 - Elsevier
Heart failure (HF) is a progressive, debilitating condition characterized, in part, by altered
ionic equilibria, increased ROS production and impaired cellular energy metabolism …

Altered heart rate turbulence and variability parameters predict 1-year mortality in heart failure with preserved ejection fraction

J Ksela, L Rupert, A Djordjevic, M Antonic… - Journal of …, 2022 - mdpi.com
Background: Heart failure with preserved ejection fraction (HFpEF) is a complex and
heterogeneous clinical syndrome. In the absence of effective and potent treatment …

Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review

H Hiraiwa, T Okumura, T Murohara - American Journal of Cardiovascular …, 2024 - Springer
In this comprehensive state-of-the-art review, we provide an evidence-based analysis of
current drug therapies for patients with heart failure with preserved ejection fraction (HFpEF) …

Clinical characteristics and factors associated with heart failure readmission at a Tertiary Hospital in North‐Eastern Tanzania

AM Sadiq, NG Chamba, AM Sadiq… - Cardiology …, 2020 - Wiley Online Library
Introduction. Heart failure (HF) is characterized by frequent episodes of decompensation,
leading to a high hospitalization burden. More than 50% of index hospitalizations for HF …

[HTML][HTML] Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and …

P Bhattacharjee, Z Khan - Cureus, 2023 - ncbi.nlm.nih.gov
There exists a paucity of research data reported by analyses performed on randomized
clinical trials (RCTs) that encompass quality of life (QOL) and the aftermath for patients …

[HTML][HTML] Heart function assessment during aging in apolipoprotein E knock-out mice

EA Liehn, AM Lupan, R Diaconu, M Ioana, I Streata… - Discoveries, 2021 - ncbi.nlm.nih.gov
BACKGROUND: Apolipoprotein (apo) E isoforms have strong correlations with metabolic
and cardiovascular diseases. However, it is not clear if apoE has a role in development of …

Embryonic alcohol exposure in zebrafish predisposes adults to cardiomyopathy and diastolic dysfunction

O Weeks, X Gao, S Basu, J Galdieri… - Cardiovascular …, 2024 - academic.oup.com
Aims Fetal alcohol spectrum disorders (FASDs) impact up to 0.8% of the global population.
However, cardiovascular health outcomes in adult patients, along with predictive biomarkers …